Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cohen & Steers

74.56
+0.36000.49%
Post-market: 74.560.00000.00%16:26 EDT
Volume:145.90K
Turnover:10.88M
Market Cap:3.80B
PE:23.70
High:75.51
Open:74.43
Low:74.21
Close:74.20
52wk High:110.67
52wk Low:68.99
Shares:51.00M
Float Shares:27.58M
Volume Ratio:0.81
T/O Rate:0.53%
Dividend:2.42
Dividend Rate:3.25%
EPS(TTM):3.15
EPS(LYR):3.00
ROE:32.55%
ROA:14.88%
PB:7.19
PE(LYR):24.85

Loading ...

Press Release: NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update

Dow Jones
·
Yesterday

Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador

GlobeNewswire
·
Yesterday

Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway

GlobeNewswire
·
Yesterday

Plus Therapeutics Presents Positive ReSPECT-LM Clinical Trial Results of REYOBIQ™ in Leptomeningeal Metastases

GlobeNewswire
·
Aug 18

BRIEF-Cohen & Steers Inc Enters $100 Million Credit Facility Agreement

Reuters
·
Aug 16

Cohen & Steers Inc - Enters $100 Mln Credit Facility Agreement - SEC Filing

THOMSON REUTERS
·
Aug 16

Cohen & Steers Inc. Amends $100 Million Credit Agreement with Bank of America and State Street Bank, Extending Maturity to 2029

Reuters
·
Aug 16

CNS Pharmaceuticals reports Q2 EPS ($6.42) vs. ($4,049.20) last year

TIPRANKS
·
Aug 15

CNS Pharmaceuticals sees cash runway into 2H26

TIPRANKS
·
Aug 15

Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements

GlobeNewswire
·
Aug 15

CNS Pharmaceuticals Q2 EPS $(6.42) Beats $(9.60) Estimate

Benzinga
·
Aug 15

Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire
·
Aug 15

Plus Therapeutics Reports Second Quarter Financial Results and Recent Business Highlights

GlobeNewswire
·
Aug 15

Cassava Reports Q2 2025 Financials Results and Provides Business Update

GlobeNewswire
·
Aug 14

Plus Therapeutics Presents Positive CNSide CSF Assay Platform Results at the 2025 SNO/ASCO CNS Metastases Conference

GlobeNewswire
·
Aug 14

Cellectar Biosciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

GlobeNewswire
·
Aug 14

SLGI Asset Management Inc. Announces Key Changes to Mutual Fund Line-Up, Including Sub-Advisor Replacements and Fund Closure

Reuters
·
Aug 14

Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire
·
Aug 12

Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update

GlobeNewswire
·
Aug 12

LG CNS to Expand AI Data Center Business into Vietnam with VNPT

MT Newswires Live
·
Aug 12